Related Experiment Video
Updated: Sep 3, 2026

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
Prevalence and Progression of Subtypes of Gastric Premalignant Lesions: A Systematic Review & Meta-Analysis
Yendé Grell1, Duco T Mülder2, Anne I Hahn3
1Weill Cornell Medical College of Cornell University, New York, NY, USA.
Background And Aims:
Gastric intestinal metaplasia (IM) and dysplasia are precursor lesions for gastric cancer (GC). This systematic review and meta-analysis examined the global prevalence and progression rates of subtypes of these understudied lesions.
Methods:
We searched databases for publications reporting prevalence and progression of subtypes of IM and dysplasia among individuals undergoing endoscopy, including incomplete/complete IM, limited (antrum-restricted)/extensive (corpus-involving) IM, and low-grade dysplasia (LGD)/high-grade dysplasia (HGD). Random-effects models were used to estimate pooled prevalence and progression rates to GC. I2 statistic was used to determine heterogeneity.
Results:
83 studies were included for prevalence and 23 for progression. The prevalence of complete IM was 11% (95% confidence interval (CI) 8-15%) and incomplete IM was 10% (6-14%), with corresponding progression rates of 1.73 (1.08-2.79) vs. 12.15 (5.28-27.94) per 1000 person-years, respectively (p <0.01). The prevalence of limited vs. extensive IM was 12% (8-17%) vs. 5% (4-8%), respectively, and corresponding progression rates were 3.31 (1.18-9.32) vs. 4.19 (0.95-18.41) per 1000 person-years (p=0.80). The prevalence of LGD was 2% (1-4%) and HGD was 0.28% (0.14-0.55%), with corresponding progression rates of 11.55 (5.93-22.47) vs. 344.48 (144.88-819.09, p <0.01). Substantial heterogeneity was observed for all estimates.
Conclusion:
While lesion subtypes with high progression risk like incomplete IM account for a large portion of the total burden of precancerous lesions, subtyping remains underutilized in clinical practice. While estimates are limited by heterogeneity, differences in progression rates between lesion subtypes support risk-stratification of these lesions within management guidelines, particularly complete vs. incomplete IM and LGD vs. HGD.
Related Concept Videos
Gastritis II: Pathophysiology
Peptic Ulcer
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...